Therapeutic base editing in the adult liver

被引：0
|
作者：
Coen C. Paulusma
Piter J. Bosma
机构：
[1] Amsterdam UMC,Tytgat Institute for Liver and Intestinal Research, AGEM
[2] University of Amsterdam,undefined
来源：
Nature Reviews Gastroenterology & Hepatology | 2021年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gene editing to correct inherited liver disorders has promise for future therapeutic intervention, but lack of effective and safe delivery of the gene-editing machinery to hepatocytes complicates its clinical application. Two studies now report efficient delivery to the liver of non-human primates, providing proof of concept for novel treatment of inherited hypercholesterolaemia.
引用
下载
收藏
页码：597 / 598
页数：1
相关论文
共 50 条
  • [31] Therapeutic applications of gene editing in chronic liver diseases: an update
    Shin, Ji Hyun
    Lee, Jinho
    Jung, Yun Kyung
    Kim, Kyeong Sik
    Jeong, Jaemin
    Choi, Dongho
    BMB REPORTS, 2022, 55 (06) : 251 - 258
  • [32] Rapid in vivo multiplexed editing (RIME) of the adult mouse liver
    Katsuda, Takeshi
    Cure, Hector
    Sussman, Jonathan
    Simeonov, Kamen P.
    Krapp, Christopher
    Arany, Zoltan
    Grompe, Markus
    Stanger, Ben Z.
    HEPATOLOGY, 2023, 78 (02) : 486 - 502
  • [33] Adenine base editing and prime editing of chemically derived hepatic progenitors rescue genetic liver disease
    Kim, Yohan
    Hong, Sung-Ah
    Yu, Jihyeon
    Eom, Jeongyun
    Jang, Kiseok
    Yoon, Sangtae
    Hong, Da Hee
    Seo, Daekwan
    Lee, Seu-Na
    Woo, Jae-Sung
    Jeong, Jaemin
    Bae, Sangsu
    Choi, Dongho
    CELL STEM CELL, 2021, 28 (09) : 1614 - +
  • [34] Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct
    Kim, Seongchan
    Jeong, You Kyeong
    Cho, Chang Sik
    Lee, SeokHoon
    Sohn, Chang Ho
    Kim, Jeong Hun
    Jeong, Youngdo
    Jo, Dong Hyun
    Bae, Sangsu
    Lee, Hyojin
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (04)
  • [35] Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa
    Hong, Sung-Ah
    Kim, Song-Ee
    Lee, A-Young
    Hwang, Gue-Ho
    Kim, Jong Hoon
    Iwata, Hiroaki
    Kim, Soo-Chan
    Bae, Sangsu
    Lee, Sang Eun
    MOLECULAR THERAPY, 2022, 30 (08) : 2664 - 2679
  • [36] Base editing of the mutated TERT promoter inhibits liver tumor growth
    Zhao, Gaoxiang
    Ma, Qingxia
    Yang, Huang
    Jiang, Hongfei
    Xu, Qianqian
    Luo, Shudi
    Meng, Zhaoyuan
    Liu, Juanjuan
    Zhu, Lei
    Lin, Qian
    Li, Min
    Fang, Jing
    Ma, Leina
    Qiu, Wensheng
    Mao, Zhengwei
    Lu, Zhimin
    HEPATOLOGY, 2024, 79 (06) : 1310 - 1323
  • [37] Potential CRISPR Base Editing Therapeutic Options in a Sorsby Fundus Dystrophy Patient
    Elsayed, Maram E. A. Abdalla
    Kaukonen, Maria
    Kiraly, Peter
    Kapetanovic, Jasmina Cehajic
    MacLaren, Robert E. E.
    GENES, 2022, 13 (11)
  • [38] Therapeutic Base and Prime Editing in Fanconi Anemia Hematopoietic Stem and Progenitor Cells
    Ugalde, L.
    Karasu, M. E.
    Olalla, B.
    Siegner, S.
    Garcia, L.
    Clemens, A.
    Alvarez, L.
    Pena, I.
    Bueren, J. A.
    Corn, J. E.
    Rio, P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A62 - A63
  • [39] CRISPR base editing as a potential therapeutic approach for Kir7.1 channelopathy
    Kabra, Meha
    Shahi, Pawan K.
    Spillane, Allison
    Wang, Yuyuan
    Sinha, Divya
    Newby, Gregory A.
    Saxena, Shivani
    Saha, Krishanu
    Moosajee, Mariya
    Gamm, David
    Liu, David R.
    Gong, Shaoqin
    Pattnaik, Bikash R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [40] Gene and Base Editing as a Therapeutic Option for Cystic FibrosisLearning from Other Diseases
    Mention, Karen
    Santos, Lucia
    Harrison, Patrick T.
    GENES, 2019, 10 (05)
12345